表紙
市場調查報告書

全球細胞治療技術市場預測(2020∼2030年):消耗品,設備,系統軟體,細胞處理/設備,保存,分配,處理,流程監測/品管,人/動物細胞,生命科學/研究企業

Cell Therapy Technologies Market Forecast 2020-2030: Consumables, Equipment, System & Software, Cell Processing/Equipment, Preservation, Distribution, Handling, Process Monitoring/Quality Control, Human/Animal Cells, Life Sciences/Research Companies

出版商 Visiongain Ltd 商品編碼 933205
出版日期 內容資訊 英文 201 Pages
商品交期: 最快1-2個工作天內
價格
全球細胞治療技術市場預測(2020∼2030年):消耗品,設備,系統軟體,細胞處理/設備,保存,分配,處理,流程監測/品管,人/動物細胞,生命科學/研究企業 Cell Therapy Technologies Market Forecast 2020-2030: Consumables, Equipment, System & Software, Cell Processing/Equipment, Preservation, Distribution, Handling, Process Monitoring/Quality Control, Human/Animal Cells, Life Sciences/Research Companies
出版日期: 2020年02月19日內容資訊: 英文 201 Pages
簡介

預計全球細胞治療技術市場今後將以15%的年複合成長率擴大。預計2020年,北美佔全球細胞治療技術市場的38%。

本報告提供全球細胞治療技術市場相關調查,市場概要和各市場區隔趨勢,各地區趨勢,及參與企業的簡介相關資訊彙整。

第1章 報告概要

第2章 細胞治療技術的簡介

第3章 市場概要

  • 波特五力分析
  • 主要的競爭趨勢
  • 推動市場的要素
    • 幹細胞技術的崛起
    • 外傷和慢性疾病的罹患率上升
    • 外科技術和監測設備的進步
    • 生物製造業的單回使用技術需求的增加
  • 阻礙市場的要素
    • 工作的非效率化
    • 嚴格的法律規章政策與倫理的問題
    • 治療成本高
  • 市場機會
    • 幹細胞的應用機會
    • 新興經濟的核心競爭力

第4章 各產品類型市場

  • 消耗品
  • 設備
  • 系統,軟體

第5章 各流程類型市場

  • 細胞處理
  • 細胞保存,分配,處理,
  • 流程監測/品管

第6章 各細胞類型市場

  • 人細胞
  • 動物細胞

第7章 各終端用戶市場預測與分析

第8章 各地區市場預測

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第9章 企業簡介

  • ThermoFisher Scientific Inc.
  • Sartorius Group
  • Merck KGaA
  • General Electric Company (GE Healthcare)
  • Danaher Corporation
  • Terumo BCT, Inc.
  • Becton, Dickinson and Company
  • Lonza Group
  • Stemcell Technologies
  • Miltenyi Biotec

第10章 結論

第11章 用語

目錄
Product Code: PHA0714

Title:
Cell Therapy Technologies Market Forecast 2020-2030
Consumables, Equipment, System & Software, Cell Processing, Cell Processing Equipment, Single Use Equipment, Cell Preservation, Distribution, Handling, Process Monitoring & Quality Control, Human Cells, Animal Cells, Life Sciences & Research Companies, Research Institutes.

Visiongain estimates that the global cell therapy technologies market will grow at a CAGR of 15% in the first half of the forecast period. In 2020, North America is estimated to hold 38% of the global cell therapy technologies market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 201-page report you will receive 104 tables and 110 figures - all unavailable elsewhere.

The 201-page report provides clear detailed insight into the cell therapy technologies market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Cell Therapy Technologies Market from 2020-2030.

Forecast of the Global Cell Therapy Technologies Market by Type of Product:

  • Consumables
  • Equipment: Cell Processing Equipment, Single Use Equipment, Other Equipment
  • System & Software

Forecast of the Global Cell Therapy Technologies by Process Type:

  • Cell processing
  • Cell preservation, distribution and handling
  • Process monitoring and quality control

Forecast of the Global Cell Therapy Technologies by Cell Type:

  • Human cells: Stem cells, Differentiated cells
  • Animal cells

Forecast of the Global Cell Therapy Technologies by End User:

  • Life Sciences and Research Companies
  • Research Institutes

This report provides individual revenue forecasts to 2030 for these national markets:

  • The US
  • Canada
  • Mexico
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Russia
  • Brazil
  • Argentina
  • UAE
  • South Africa
  • Nigeria
  • Mexico

Our study discusses the selected leading companies that are the major players in the respiratory inhalers market:

  • GE Healthcare
  • Lonza Group
  • Merck KGaA
  • Terumo Bct, Inc.
  • Thermo Fisher Scientific, Inc.
  • & Other Companies

For the leading companies, we feature product portfolios, business segment breakdowns, recent developments & key expansion strategies etc.

This report discusses factors that drive and restrain this market. As well as opportunities and challenges faced by this market.

This report discusses the Porter's Five Forces Analysis of the Cell Therapy Technologies Market.

Key questions answered by this report:

  • How is the Cell Therapy Technologies Market evolving?
  • What is driving and restraining factors of the Cell Therapy Technologies Market?
  • What are the market shares of each segment of the overall Cell Therapy Technologies Market in 2020?
  • How will each Cell Therapy Technologies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2030?
  • How will the market shares for each Cell Therapy Technologies submarket develop from 2021 to 2030?
  • What will be the main driver for the overall market from 2021 to 2030?
  • Will leading national Cell Therapy Technologies Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2030 and which geographical region will lead the market in 2030?
  • Who are the leading players and what are their prospects over the forecast period?
  • How will the industry evolve during the period between 2020 and 2030?

Visiongain's study is intended for anyone requiring commercial analyses for the Cell Therapy Technologies Market. You find data, trends and predictions.

Buy our report today Cell Therapy Technologies Market Forecast 2020-2030: Consumables, Equipment, System & Software, Cell Processing, Cell Processing Equipment, Single Use Equipment, Cell Preservation, Distribution, Handling, Process Monitoring & Quality Control, Human Cells, Animal Cells, Life Sciences & Research Companies, Research Institutes.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 Global Cell Therapy Technologies Market Overview
  • 1.2 Market Definition and Methodology
  • 1.3 Cell Therapy Technologies Market Report Structure
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
  • 1.8 Frequently Asked Questions (FAQ)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2. Introduction to the Cell Therapy Technologies Market

  • 2.1 What is Cell Therapy Technology?
  • 2.2 Type of Cell Therapy Technologies
  • 2.3 Key examples of Cell Therapy Technologies

3. Market Overview Cell Therapy Technologies Market

  • 3.1 Porter's Five Forces Analysis of Cell Therapy Technologies Market
    • 3.1.1 Moderate supplier Bargaining Power
    • 3.1.2 Low bargaining power of buyer
    • 3.1.3 Low-level threats from substitute products
    • 3.1.4 High-level threats from new entrants
    • 3.1.5 High competition from industry players
  • 3.2 Key Competitive Landscape for Cell Therapy Technologies
  • 3.3 Global Cell Therapy Technologies Market Drivers
    • 3.3.1 Emergence of Stem Cell Technology
    • 3.3.2 Rise in Prevalence of Trauma Emergencies and Chronic Diseases
    • 3.3.3 Advancement in Surgical Technologies and Monitoring Devices
    • 3.3.4 Increase in the demand for single-use technologies in bio manufacturing
  • 3.4 Global Cell Therapy Technologies Market Restraints
    • 3.4.1 Operational Inefficiency
    • 3.4.2 Stringent Regulatory Policies & Ethical Issues
    • 3.4.3 High Cost of Treatments
  • 3.5 Global Cell Therapy Technologies Market Opportunities
    • 3.5.1 Opportunities in Stem Cell Applications
    • 3.5.2 Core Competency in Emerging Economies

4. Cell Therapy technologies Market by Product Type 2020-2030

  • 4.1 Cell Therapy Technologies Market for Consumables Forecasts 2020-2030
  • 4.2 Cell Therapy Technologies Market for Equipment Forecasts 2020-2030
    • 4.2.1 Equipment Market by Type 2020-2030
      • 4.2.1.1 Cell Processing Equipment Market Forecasts 2020-2030
      • 4.2.1.2 Single Use Equipment Market Forecasts 2020-2030
      • 4.2.1.3 Other Equipment Market Forecasts 2020-2030
  • 4.3 Cell Therapy Technologies Market for System & Software Forecasts 2020-2030

5. Cell Therapy Technologies Market by Process Type 2020-2030

  • 5.1 Cell Therapy Technologies Market for Cell Processing Forecasts 2020-2030
  • 5.2 Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling Forecasts 2020-2030
  • 5.3 Cell Therapy Technologies Market for Process Monitoring and Quality Control Forecasts 2020-2030

6. Cell Therapy technologies Market by Cell Type 2020-2030

  • 6.1 Cell Therapy Technologies Market for Human Cells Forecasts 2020-2030
    • 6.1.1 Human Cells Market by Type 2020-2030
      • 6.1.1.1 Human Cells Market for Stem Cells Forecasts 2020-2030
      • 6.1.1.2 Human Cells Market for Differentiated Cells Forecasts 2020-2030
  • 6.2 Cell Therapy Technologies Market for Animal Cells Forecasts 2020-2030

7. Cell Therapy Technologies Market by End User: Forecast & Analysis 2020-2030

  • 7.1 Cell Therapy Technologies Market for Life Sciences and Research Company Forecasts 2020-2030
  • 7.2 Cell Therapy Technologies Market for Research Institutes Forecasts 2020-2030

8. Regional Cell Therapy Technologies Market Forecasts 2020-2030

  • 8.1 North American Cell Therapy Technologies Market Forecasts 2020-2030
    • 8.1.1 North America Cell Therapy Technologies Market Forecasts by Country 2020-2030
      • 8.1.1.1 U.S. Cell Therapy Technologies Market Forecasts 2020-2030
      • 8.1.1.2 Canada Cell Therapy Technologies Market Forecasts 2020-2030
      • 8.1.1.3 Mexico Cell Therapy Technologies Market Forecasts 2020-2030
    • 8.1.2 North America Cell Therapy Technologies Market Forecasts by Product Type 2020-2030
    • 8.1.3 North America Cell Therapy Technologies Market Forecasts by Process 2020-2030
    • 8.1.4 North America Cell Therapy Technologies Market Forecasts by Cell Type 2020-2030
    • 8.1.5 North America Cell Therapy Technologies Market Forecasts by End User 2020-2030
  • 8.2 Europe Cell Therapy Technologies Market Forecasts 2021-2030
    • 8.2.1 Europe Cell Therapy Technologies Market Forecasts by Country 2020-2030
      • 8.2.1.1 Germany Cell Therapy Technologies Market Forecasts 2020-2030
      • 8.2.1.2 UK Cell Therapy Technologies Market Forecasts 2020-2030
      • 8.2.1.3 France Cell Therapy Technologies Market Forecasts 2020-2030
      • 8.2.1.4 Russia Cell Therapy Technologies Market Forecasts 2020-2030
      • 8.2.1.5 Spain Cell Therapy Technologies Market Forecasts 2020-2030
      • 8.2.1.6 Italy Cell Therapy Technologies Market Forecasts 2020-2030
      • 8.2.1.7 Rest of Europe Cell Therapy Technologies Market Forecasts 2020-2030
    • 8.2.2 Europe Cell Therapy Technologies Market Forecasts by Product Type 2020-2030
    • 8.2.3 Europe Cell Therapy Technologies Market Forecasts by Process 2020-2030
    • 8.2.4 Europe Cell Therapy Technologies Market Forecasts by Cell Type 2020-2030
    • 8.2.5 Europe Cell Therapy Technologies Market Forecasts by End User 2020-2030
  • 8.3 Asia-Pacific Cell Therapy Technologies Market Forecasts 2020-2030
    • 8.3.1 Asia Pacific Cell Therapy Technologies Market Forecasts by Country 2020-2030
      • 8.3.1.1 China Cell Therapy Technologies Market Forecasts 2020-2030
      • 8.3.1.2 Japan Cell Therapy Technologies Market Forecasts 2020-2030
      • 8.3.1.3 India Cell Therapy Technologies Market Forecasts 2020-2030
      • 8.3.1.4 South Korea Cell Therapy Technologies Market Forecasts 2020-2030
      • 8.3.1.5 Singapore Cell Therapy Technologies Market Forecasts 2020-2030
      • 8.3.1.6 Malaysia Cell Therapy Technologies Market Forecasts 2020-2030
      • 8.3.1.7 Rest of Asia Pacific Cell Therapy Technologies Market Forecasts 2020-2030
    • 8.3.2 Asia Pacific Cell Therapy Technologies Market Forecasts by Product Type 2020-2030
    • 8.3.3 Asia Pacific Cell Therapy Technologies Market Forecasts by Process 2020-2030
    • 8.3.4 Asia Pacific Cell Therapy Technologies Market Forecasts by Cell Type 2020-2030
    • 8.3.5 Asia Pacific Cell Therapy Technologies Market Forecasts by End User 2020-2030
  • 8.4 Rest of the World (RoW) Cell Therapy Technologies Market Forecasts 2020-2030
    • 8.4.1 RoW Cell Therapy Technologies Market Forecasts by Country 2020-2030
      • 8.4.1.1 Brazil Cell Therapy Technologies Market Forecasts 2020-2030
      • 8.4.1.2 Argentina Cell Therapy Technologies Market Forecasts 2020-2030
      • 8.4.1.3 UAE Cell Therapy Technologies Market Forecasts 2020-2030
      • 8.4.1.4 Saudi Arabia Cell Therapy Technologies Market Forecasts 2020-2030
      • 8.4.1.5 South Africa Cell Therapy Technologies Market Forecasts 2020-2030
      • 8.4.1.6 Nigeria Cell Therapy Technologies Market Forecasts 2020-2030
      • 8.4.1.7 Rest of ROW Cell Therapy Technologies Market Forecasts 2020-2030
    • 8.4.2 RoW Cell Therapy Technologies Market Forecasts by Product Type 2020-2030
    • 8.4.3 RoW Cell Therapy Technologies Market Forecasts by Process 2020-2030
    • 8.4.4 RoW Cell Therapy Technologies Market Forecasts by Cell Type 2020-2030
    • 8.4.5 RoW Cell Therapy Technologies Market Forecasts by End User 2020-2030

9. Leading Companies in the Cell Therapy Technologies Market

  • 9.1 ThermoFisher Scientific Inc.
    • 9.1.1 ThermoFisher Scientific Inc.: Business Overview
    • 9.1.2 ThermoFisher Scientific Inc.: Product Portfolio
    • 9.1.3 ThermoFisher Scientific Inc.: Financial Overview
    • 9.1.4 ThermoFisher Scientific Inc.: Recent Developments
  • 9.2 Sartorius Group
    • 9.2.1 Sartorius Group: Business Overview
    • 9.2.2 Sartorius Group: Product Portfolio
    • 9.2.3 Sartorius Group: Financial Overview
    • 9.2.4 Sartorius Group: Recent Developments
  • 9.3 Merck KGaA
    • 9.3.1 Merck KGaA: Business Overview
    • 9.3.2 Merck KGaA: Product Portfolio
    • 9.3.3 Merck KGaA: Financial Overview
    • 9.3.4 Merck KGaA: Recent Developments
  • 9.4 General Electric Company (GE Healthcare)
    • 9.4.1 General Electric Company (GE Healthcare): Business Overview
    • 9.4.2 GE Healthcare: Product Portfolio
    • 9.4.3 General Electric Company: Financial Overview
    • 9.4.4 General Electric Company: Recent Developments
  • 9.5 Danaher Corporation
    • 9.5.1 Danaher Corporation: Business Overview
    • 9.5.2 Danaher Corporation: Product Portfolio
    • 9.5.3 Danaher Corporation: Financial Overview
    • 9.5.4 Danaher Corporation: Recent Developments
  • 9.6 Terumo BCT, Inc.
    • 9.6.1 Terumo BCT, Inc.: Business Overview
    • 9.6.2 Terumo BCT, Inc.: Product Portfolio
    • 9.6.3 Terumo BCT, Inc.: Financial Overview
    • 9.6.4 Terumo BCT, Inc.: Recent Developments
  • 9.7 Becton, Dickinson and Company
    • 9.7.1 Becton, Dickinson and Company: Business Overview
    • 9.7.2 Becton, Dickinson and Company: Product Portfolio
    • 9.7.3 Becton, Dickinson and Company: Financial Overview
    • 9.7.4 Becton, Dickinson and Company: Recent Developments
  • 9.8 Lonza Group
    • 9.8.1 Lonza Group: Business Overview
    • 9.8.2 Lonza Group: Product Portfolio
    • 9.8.3 Lonza Group: Financial Overview
    • 9.8.4 Lonza Group: Recent Developments
  • 9.9 Stemcell Technologies
    • 9.9.1 Stemcell Technologies: Product Portfolio
    • 9.9.2 Stemcell Technologies: Recent Developments
  • 9.10 Miltenyi Biotec
    • 9.10.1 Miltenyi Biotec: Product Portfolio
    • 9.10.2 Miltenyi Biotec: Recent Developments

10. Conclusions

  • 10.1 Current Leading Cell Therapy Technologies Market Segments
  • 10.2 Leading Cell therapy technologies Companies
  • 10.3 Leading Regional Markets
  • 10.4 Emerging Cell Therapy Technologies Markets

11. Glossary

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
    • About Visiongain
  • Appendix B
    • Visiongain report evaluation form

List of Tables:

  • Table 4.1 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by Product Type, ($bn, AGR%, CAGR%) 2020-2030
  • Table 4.2 Cell Therapy Technologies Market for Consumables: Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 4.3 Cell Therapy Technologies Market for Consumables, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030
  • Table 4.4 Cell Therapy Technologies Market for Equipment: Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 4.5 Cell Therapy Technologies Market for Equipment, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030
  • Table 4.6 Equipment Market by Type Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 4.7 Cell Processing Equipment Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 4.8 Single Use Equipment Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 4.9 Other Equipment Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 4.10 Cell Therapy Technologies Market for System & Software: Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 4.11 Cell Therapy Technologies Market for System & Software, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030
  • Table 5.1 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by Process Type, ($bn, AGR%, CAGR%) 2020-2030
  • Table 5.2 Cell Therapy Technologies Market for Cell Processing: Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 5.3 Cell Therapy Technologies Market for Cell Processing, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030
  • Table 5.4 Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling: Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 5.5 Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030
  • Table 5.6 Cell Therapy Technologies Market for Process Monitoring and Quality Control: Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 5.7 Cell Therapy Technologies Market for Process Monitoring and Quality Control, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030
  • Table 6.1 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by Cell Type, ($bn, AGR%, CAGR%) 2020-2030
  • Table 6.2 Cell Therapy Technologies Market for Human Cells: Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 6.3 Cell Therapy Technologies Market for Human Cells, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030
  • Table 6.4 Human Cells Market by Type Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 6.5 Human Cells Market for Stem Cells Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 6.6 Human Cells Market for Differentiated Cells Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 6.7 Cell Therapy Technologies Market for Animal Cells: Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 6.8 Cell Therapy Technologies Market for Animal Cells, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030
  • Table 7.1 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by End User, ($bn, AGR%, CAGR%) 2020-2030
  • Table 7.2 Cell Therapy Technologies Market for Life Sciences and Research Companies: Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 7.3 Cell Therapy Technologies Market for Life Sciences and Research Companies, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030
  • Table 7.4 Cell Therapy Technologies Market for Research institutes: Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 7.5 Cell Therapy Technologies Market for Research Institutes, by Region, Forecast ($bn, AGR%, CAGR%) 2020-2030
  • Table 8.1 Regional Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.2 North America Cell Therapy Technologies Market, by Country ($bn, AGR%, CAGR%) 2020-2030
  • Table 8.3 U.S. Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.4 Canada Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.5 Mexico Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.6 North America Cell Therapy Technologies Market Forecasts, by Product Type ($bn, AGR% CAGR%) 2020-2030
  • Table 8.7 North America Cell Therapy Technologies Market Forecasts, by Process ($bn, AGR% CAGR%) 2020-2030
  • Table 8.8 North America Cell Therapy Technologies Market Forecasts, by Cell Type ($bn, AGR% CAGR%) 2020-2030
  • Table 8.9 North America Cell Therapy Technologies Market Forecasts, by End User ($bn, AGR% CAGR%) 2020-2030
  • Table 8.10 Europe Cell Therapy Technologies Market, by Country ($bn, AGR%, CAGR%) 2020-2030
  • Table 8.11 Germany Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.12 UK Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.13 France Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.14 Russia Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.15 Spain Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.16 Italy Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.17 Rest of Europe Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.18 Europe Cell Therapy Technologies Market Forecasts, by Product Type ($bn, AGR% CAGR%) 2020-2030
  • Table 8.19 Europe Cell Therapy Technologies Market Forecasts, by Process ($bn, AGR% CAGR%) 2020-2030
  • Table 8.20 Europe Cell Therapy Technologies Market Forecasts, by Cell Type ($bn, AGR% CAGR%) 2020-2030
  • Table 8.21 Europe Cell Therapy Technologies Market Forecasts, by End User ($bn, AGR% CAGR%) 2020-2030
  • Table 8.22 Asia Pacific Cell Therapy Technologies Market, by Country ($bn, AGR%, CAGR%) 2020-2030
  • Table 8.23 China Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.24 Japan Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.25 India Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.26 South Korea Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.27 Singapore Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.28 Malaysia Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.29 Rest of Asia Pacific Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.30 Asia Pacific Cell Therapy Technologies Market Forecasts, by Product Type ($bn, AGR% CAGR%) 2020-2030
  • Table 8.31 Asia Pacific Cell Therapy Technologies Market Forecasts, by Process ($bn, AGR% CAGR%) 2020-2030
  • Table 8.32 Asia Pacific Cell Therapy Technologies Market Forecasts, by Cell Type ($bn, AGR% CAGR%) 2020-2030
  • Table 8.33 Asia Pacific Cell Therapy Technologies Market Forecasts, by End User ($bn, AGR% CAGR%) 2020-2030
  • Table 8.34 Rest of the World (RoW) Cell Therapy Technologies Market, by Country ($bn, AGR%, CAGR%) 2020-2030
  • Table 8.35 Brazil Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.36 Argentina Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.37 UAE Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.38 Saudi Arabia Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.39 South Africa Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.40 Nigeria Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2020
  • Table 8.41 Rest of ROW Cell Therapy Technologies Market Forecasts ($bn, AGR% CAGR%) 2020-2030
  • Table 8.42 RoW Cell Therapy Technologies Market Forecasts, by Product Type ($bn, AGR% CAGR%) 2020-2030
  • Table 8.43 RoW Cell Therapy Technologies Market Forecasts, by Process ($bn, AGR% CAGR%) 2020-2030
  • Table 8.44 RoW Cell Therapy Technologies Market Forecasts, by Cell Type ($bn, AGR% CAGR%) 2020-2030
  • Table 8.45 RoW Cell Therapy Technologies Market Forecasts, by End User ($bn, AGR% CAGR%) 2020-2030
  • Table 9.1 ThermoFisher Scientific Inc.: Business Overview
  • Table 9.2 ThermoFisher Scientific Inc.: Product Portfolio
  • Table 9.3 ThermoFisher Scientific Inc.: Recent Developments
  • Table 9.4 Sartorius Group: Business Overview
  • Table 9.5 Sartorius Group: Product Portfolio
  • Table 9.6 Sartorius Group: Recent Developments
  • Table 9.7 Merck KGaA: Business Overview
  • Table 9.8 Merck KGaA: Product Portfolio
  • Table 9.9 Merck KGaA: Recent Developments
  • Table 9.10 GE Healthcare: Business Overview
  • Table 9.11 GE Healthcare: Product Portfolio
  • Table 9.12 GE Healthcare: Recent Developments
  • Table 9.13 Danaher Corporation: Business Overview
  • Table 9.14 Danaher Corporation: Product Portfolio
  • Table 9.15 Danaher Corporation: Recent Developments
  • Table 9.16 Terumo BCT, Inc.: Business Overview
  • Table 9.17 Terumo BCT, Inc.: Product Portfolio
  • Table 9.18 Terumo BCT, Inc.: Recent Developments
  • Table 9.19 Becton, Dickinson and Company: Business Overview
  • Table 9.20 Becton, Dickinson and Company: Product Portfolio
  • Table 9.21 Becton, Dickinson and Company: Recent Developments
  • Table 9.22 Lonza Group: Business Overview
  • Table 9.23 Lonza Group: Product Portfolio
  • Table 9.24 Lonza Group: Recent Developments
  • Table 9.25 Stemcell Technologies: Product Portfolio
  • Table 9.26 Stemcell Technologies: Recent Developments
  • Table 9.27 Miltenyi Biotec: Product Portfolio
  • Table 9.28 Miltenyi Biotec: Recent Developments

List of Figures:

  • Figure 1.1 Global Cell Therapy Technologies Market Segmentation Overview
  • Figure 3.2 Global Cell Therapy Technologies Market, Key Strategies share (%)
  • Figure 3.3 Global Cell Therapy Technologies Market: Leading company with number of strategies
  • Figure 4.1 Global Cell Therapy Technologies Market by Product Type, 2020 (% Share)
  • Figure 4.2 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by Product Type, ($bn, AGR%, CAGR%) 2020-2030
  • Figure 4.3 Cell Therapy Technologies Market for Consumables: Forecasts ($bn), 2020-2030
  • Figure 4.4 Cell Therapy Technologies Market for Consumables, by Region: Forecasts ($bn), 2020-2030
  • Figure 4.5 Cell Therapy Technologies Market for Equipment: Forecasts ($bn), 2020-2030
  • Figure 4.6 Cell Therapy Technologies Market for Equipment, by Region: Forecasts ($bn), 2020-2030
  • Figure 4.7 Equipment Market by type, 2020 (%share)
  • Figure 4.8 Cell Processing Equipment Market Forecasts ($bn), 2020-2030
  • Figure 4.9 Single Use Equipment Market Forecasts ($bn), 2020-2030
  • Figure 4.10 Other Equipment Market Forecasts ($bn), 2020-2030
  • Figure 4.11 Cell Therapy Technologies Market for System & Software: Forecasts ($bn), 2020-2030
  • Figure 4.12 Cell Therapy Technologies Market for System & Software, By Region: Forecasts ($bn), 2020-2030
  • Figure 5.1 Global Cell Therapy Technologies Market by Process Type, 2020, (% Share)
  • Figure 5.2 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by Process Type, ($bn, AGR%, CAGR%) 2020-2030
  • Figure 5.3 Cell Therapy Technologies Market for Cell Processing: Forecasts ($bn), 2020-2030
  • Figure 5.4 Cell Therapy Technologies Market for Cell Processing, by Region: Forecasts ($bn), 2020-2030
  • Figure 5.5 Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling: Forecasts ($bn), 2020-2030
  • Figure 5.6 Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling, by Region: Forecasts ($bn), 2020-2030
  • Figure 5.7 Cell Therapy Technologies Market for Process Monitoring and Quality Control: Forecasts ($bn), 2020-2030
  • Figure 5.8 Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling, By Region: Forecasts ($bn), 2020-2030
  • Figure 6.1 Global Cell Therapy Technologies Market by Cell Type, 2020, (% Share)
  • Figure 6.2 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by Cell Type, ($bn, AGR%, CAGR%) 2020-2030
  • Figure 6.3 Cell Therapy Technologies Market for Human Cells: Forecasts ($bn), 2020-2030
  • Figure 6.4 Cell Therapy Technologies Market for Human Cells, By Region: Forecasts ($bn), 2020-2030
  • Figure 6.5 Human Cells Market by type, 2020 (%share)
  • Figure 6.6 Human Cells Market for Stem Cells Forecasts ($bn), 2020-2030
  • Figure 6.7 Human Cells Market for Differentiated Cells Forecasts ($bn), 2020-2030
  • Figure 6.8 Cell Therapy Technologies Market for Animal Cells: Forecasts ($bn), 2020-2030
  • Figure 6.9 Cell Therapy Technologies Market for Animal Cells, by Region: Forecasts ($bn), 2020-2030
  • Figure 7.1 Global Cell Therapy Technologies Market by End User, 2020, (% Share)
  • Figure 7.2 Cell Therapy Technologies Market Forecast & Analysis 2020-2030, by End User, ($bn, AGR%, CAGR%) 2020-2030
  • Figure 7.3 Cell Therapy Technologies Market for Life Sciences and Research Companies: Forecasts ($bn), 2020-2030
  • Figure 7.4 Cell Therapy Technologies Market for Life Sciences and Research Companies, Market Share 2030
  • Figure 7.5 Cell Therapy Technologies Market for Life Sciences and Research Companies, By Region: Forecasts ($bn), 2020-2030
  • Figure 7.6 Cell Therapy Technologies Market for Research Institutes: Forecasts ($bn), 2020-2030
  • Figure 7.7 Cell Therapy Technologies Market for Research Institutes, by Region: Forecasts ($bn), 2020-2030
  • Figure 8.1 Regional Cell Therapy Technologies Markets Forecasts ($bn), 2020-2030
  • Figure 8.2 North America Cell Therapy Technologies Market Share Analysis, by Country (%), 2020
  • Figure 8.3 U.S. Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.4 Canada Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.5 Mexico Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.6 North America Cell Therapy Technologies Market Revenue Analysis, by Product Type, 2020-2030
  • Figure 8.7 North America Cell Therapy Technologies Market Revenue Analysis, by Process, 2020-2030
  • Figure 8.8 North America Cell Therapy Technologies Market Revenue Analysis, by Cell Type, 2020-2030
  • Figure 8.9 North America Cell Therapy Technologies Market Revenue Analysis, by End User, 2020-2030
  • Figure 8.10 Europe Cell Therapy Technologies Market Share Analysis, by Country (%), 2020
  • Figure 8.11 Germany Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.12 UK Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.13 France Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.14 Russia Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.15 Spain Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.16 Italy Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.17 Rest of Europe Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.18 Europe Cell Therapy Technologies Market Revenue Analysis, by Product Type, 2020-2030
  • Figure 8.19 Europe Cell Therapy Technologies Market Revenue Analysis, by Process, 2020-2030
  • Figure 8.20 Europe Cell Therapy Technologies Market Revenue Analysis, by Cell Type, 2020-2030
  • Figure 8.21 Europe Cell Therapy Technologies Market Revenue Analysis, by End User, 2020-2030
  • Figure 8.22 Asia Pacific Cell Therapy Technologies Market Share Analysis, by Country (%), 2020
  • Figure 8.23 China Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.24 Japan Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.25 India Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.26 South Korea Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.27 Singapore Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.28 Malaysia Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.29 Rest of Asia Pacific Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.30 Asia Pacific Cell Therapy Technologies Market Revenue Analysis, by Product Type, 2020-2030
  • Figure 8.31 Asia Pacific Cell Therapy Technologies Market Revenue ($bn) Analysis, by Process, 2020-2030
  • Figure 8.32 Asia Pacific Cell Therapy Technologies Market Revenue Analysis, by Cell Type, 2020-2030
  • Figure 8.33 Asia Pacific Cell Therapy Technologies Market Revenue Analysis, by End User, 2020-2030
  • Figure 8.34 Rest of the World (RoW) Cell Therapy Technologies Market Share Analysis, by Country (%), 2020
  • Figure 8.35 Brazil Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.36 Argentina Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.37 UAE Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.38 Saudi Arabia Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.39 South Africa Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.40 Nigeria Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.41 Rest of ROW Cell Therapy Technologies Market Forecasts ($bn), 2020-2030
  • Figure 8.42 RoW Cell Therapy Technologies Market Revenue Analysis, by Product Type, 2020-2030
  • Figure 8.43 RoW Cell Therapy Technologies Market Revenue Analysis, by Process, 2020-2030
  • Figure 8.44 RoW Cell Therapy Technologies Market Revenue Analysis, by Cell Type, 2020-2030
  • Figure 8.45 RoW Cell Therapy Technologies Market Revenue Analysis, by End User, 2020-2030
  • Figure 9.1 ThermoFisher Scientific Inc. Annual Revenue 2014-2018 ($million)
  • Figure 9.2 ThermoFisher Scientific Inc.: Business Segment Revenue Share 2018 (%)
  • Figure 9.3 ThermoFisher Scientific Inc.: Product Segment Revenue Share 2018 (%)
  • Figure 9.4 ThermoFisher Scientific Inc.: Geography Segment Revenue Share 2018 (%)
  • Figure 9.5 Sartorius Group: Annual Revenue 2014-2018 ($million)
  • Figure 9.6 Sartorius Group: Business Segment Revenue Share 2018 (%)
  • Figure 9.7 Sartorius Group: Geography Segment Revenue Share 2018 (%)
  • Figure 9.8 Merck KGaA: Annual Revenue 2014-2018 ($million)
  • Figure 9.9 Merck KGaA: Business Segment Revenue Share 2018 (%)
  • Figure 9.10 Merck KGaA: Geography Segment Revenue Share 2018 (%)
  • Figure 9.11 General Electric Company: Annual Revenue 2014-2018 ($million)
  • Figure 9.12 General Electric Company: Business Segment Revenue Share 2018(%)
  • Figure 9.13 General Electric Company: Geography Segment Revenue Share 2018 (%)
  • Figure 9.14 Danaher Corporation: Annual Revenue 2014-2018 ($million)
  • Figure 9.15 Danaher Corporation: Business Segment Revenue Share 2018(%)
  • Figure 9.16 Danaher Corporation: Geography Segment Revenue Share 2018 (%)
  • Figure 9.17 Terumo BCT, Inc.: Annual Revenue 2014-2018 ($million)
  • Figure 9.18 Terumo BCT, Inc.: Business Segment Revenue Share 2018(%)
  • Figure 9.19 Terumo BCT, Inc.: Geography Segment Revenue Share 2018 (%)
  • Figure 9.20 Becton, Dickinson and Company: Annual Revenue 2015-2019 ($million)
  • Figure 9.21 Becton, Dickinson and Company: Business Segment Revenue Share 2019 (%)
  • Figure 9.22 Becton, Dickinson and Company: Geography Segment Revenue Share 2019 (%)
  • Figure 9.23 Lonza Group: Annual Revenue 2014-2018 ($million)
  • Figure 9.24 Lonza Group: Business Segment Revenue Share 2018 (%)
  • Figure 9.25 Lonza Group: Geography Segment Revenue Share 2018 (%)
  • Figure 10.1 Cell Therapy Technologies Market Analysis, by Region ($bn, AGR%), 2020-2030

List of Companies and Organisations Mentioned: in the Report:

  • Affymetrix, Inc.
  • Akouos
  • AllCells
  • Applikon Biotechnology Inc.
  • ATLATL Centre
  • Autolus Limited
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bioengineering AG
  • Biological Industries
  • BioWa, Inc
  • Brammer Bio
  • C.R. Bard, Inc.
  • CaridianBCT, Inc
  • Cell and Gene Therapy Asia Technology Centre
  • Centre for Process Innovation (CPI)
  • CMC Biologics (Asahi Glass Co.)
  • Cobra Biologics
  • Cocoon Platform
  • Cryoport
  • Danaher Corporation
  • DiNAQOR AG
  • EMD Performance Materials
  • EMD Serono
  • Eppendorf AG
  • European Molecular Biology Laboratory (EMBL)
  • Finesse Solutions, Inc.
  • Flexsafe RM TX
  • FloDesign Sonics
  • FlowJo, LLC
  • Food and Drug Administration (FDA)
  • Gamida Cell
  • G-CON Manufacturing
  • GE healthcare
  • GenScript
  • Infors HT
  • Integrated DNA Technologies, Inc.
  • LaVision BioTec
  • Lonza Group, GE Healthcare
  • Massachusetts Eye and Ear (MEE)
  • Meissner Filtration Products, Inc.
  • Merck KGaA
  • Merck Serono
  • Mesoblast
  • MilliporeSigma
  • Miltenyi Biotec
  • Nova Biomedical
  • Pall Corporation (Pall)
  • Patheon N.V.
  • Penn State University
  • PharmaCell B.V
  • Sartorius AG
  • Sartorius Stedim Biotech
  • Scinogy
  • Selecta Biosciences, Inc
  • Siemens
  • Solaris Biotech
  • Stafa Cellular Therapy
  • StafaCT
  • Stemcell Technologies
  • Terumo Bct, Inc. (A Subsidiary of Terumo Corporation)
  • Thermo Fisher Scientific, Inc.
  • Tillotts Pharma AG
  • Transtem Lab
  • UniCAR Therapy
  • World Courier